Why cybersecurity is important to the pharmaceutical industry
The pharmaceutical sector provides crucial medications, biotech and research, and it is an increasingly lucrative target for threat actors, who often see enormous returns for their ongoing persistence. Plus, nation-states frequently want to steal drug formulas or disrupt clinical trials, which means cybersecurity for pharmaceutical organizations has never been more important.
Machine identity management is essential for authorizing and authenticating every device or service that accesses your systems, even across complicated OT, supply chains or cloud native environments. It’s an effective strategy for reducing your risk for ransomware, APTs and more.
The average cost of a breach in the pharmaceutical industry was $5.01 million in 2022.
Challenges in pharmaceutical cybersecurity
Increasing duress for data security
APTs, nation-state actors and insider threats can have insidious consequences for pharmaceutical companies. Without robust management of machine identities across your distributed systems and services, you will lack visibility into potential vulnerabilities.
Compliance and complexity
Your industry faces stringent regulations, ranging from HIPAA and CCPA to GDPR and so many more. If you can’t track increasing machine activity across your complex digital ecosystems, you can’t be sure you’re maintaining compliance.
Supply-chain risks and IIoT
Rapid digital transformation and the proliferation of the Industrial Internet of Things (IIoT) have increased supply-chain risks and the dangers of ransomware and malware—which can have ripple effects across your entire operation.
Pharmaceutical cybersecurity solutions from Venafi
No industry is immune to cyber threats, but the Venafi Control Plane can help you manage every machine identity across your pharmaceutical organization, providing unparalleled visibility and control through a centralized, automated platform.
Machine identity complexity is causing massive problems.
The perimeter is dead, and the rapid expansion of cloud native infrastructure has caused an explosion of new machine identities—and staggering levels of difficulty in managing them. Read this 1-page brief to learn how a control plane standardizes your approach to machine identity management.
Establish clear visibility of all machine identities
Leave no stone unturned. Uncover 25-30% more certificates during your discovery phase with Venafi.
Using complete discovery capabilities, you can build a centralized inventory of all machine identities to prevent outages and pinpoint system vulnerabilities across your pharmaceutical organization, including OT, connected biotech and more.
Develop thorough policies to maintain compliance
Automate 65-85% of your certificate lifecycle management.
Define and enforce company-wide machine identity policy through automation, especially critical for growing inventories of devices and services spread across complex, cloud native environments.
Validate machines to avoid APTs, ransomware and malware
Use secure code signing processes to authenticate all connected devices and services—and prevent supply-chain attacks, clinical trial disruptions or impacts to distribution.
Work the way you want
Orchestrate the protection of machine identities across the applications your pharmaceutical company is already using by integrating with our extensive technology partner Ecosystem.